HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Siwen Hu-Lieskovan Selected Research

Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)

5/2015Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Siwen Hu-Lieskovan Research Topics

Disease

43Neoplasms (Cancer)
02/2024 - 06/2005
27Melanoma (Melanoma, Malignant)
01/2024 - 07/2014
3Disease Progression
03/2023 - 09/2016
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 01/2019
3Neoplasm Metastasis (Metastasis)
12/2021 - 11/2018
2Colonic Neoplasms (Colon Cancer)
10/2016 - 08/2011
1Chronic Obstructive Pulmonary Disease (COPD)
01/2024
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2023
1Squamous Cell Carcinoma of Head and Neck
10/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022
1Brain Neoplasms (Brain Tumor)
12/2021
1Tuberculosis (Tuberculoses)
06/2021
1Immune System Diseases (Immune Disorders)
06/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2020
1Sarcoma (Soft Tissue Sarcoma)
01/2019
1Testicular Neoplasms (Testicular Cancer)
11/2018
1Colorectal Neoplasms (Colorectal Cancer)
01/2018
1Rectal Neoplasms (Rectal Cancer)
08/2011
1Ewing Sarcoma (Sarcoma, Ewing)
10/2005
1Rhabdomyosarcoma
06/2005

Drug/Important Bio-Agent (IBA)

12Immune Checkpoint InhibitorsIBA
02/2024 - 03/2016
6Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2017
5pembrolizumabIBA
03/2023 - 09/2016
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2021 - 03/2015
5LigandsIBA
11/2021 - 10/2005
5AntibodiesIBA
06/2021 - 07/2016
4NivolumabIBA
06/2023 - 12/2019
4InterferonsIBA
06/2023 - 01/2017
4IpilimumabIBA
06/2023 - 01/2019
4AntigensIBA
01/2020 - 03/2015
3Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2020
3Programmed Cell Death 1 ReceptorIBA
01/2021 - 10/2016
2RNA (Ribonucleic Acid)IBA
06/2023 - 11/2021
2utomilumabIBA
10/2022 - 09/2017
2DNA (Deoxyribonucleic Acid)IBA
11/2021 - 08/2011
2VaccinesIBA
06/2021 - 10/2020
2Cancer VaccinesIBA
12/2020 - 11/2020
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019 - 11/2018
2Neoplasm Antigens (Tumor Antigens)IBA
01/2019 - 11/2018
2CateninsIBA
01/2018 - 06/2015
2Interferon-gamma (Interferon, gamma)IBA
01/2017 - 09/2016
2dabrafenibIBA
07/2016 - 03/2015
2trametinibIBA
07/2016 - 03/2015
2EWS-FLI fusion proteinIBA
10/2005 - 06/2005
1Temozolomide (Temodar)FDA LinkGeneric
06/2023
1B7-H1 AntigenIBA
01/2023
1Death Domain ReceptorsIBA
10/2022
1CTLA-4 AntigenIBA
10/2022
1Therapeutic UsesIBA
01/2022
1Immunologic Factors (Immunomodulators)IBA
06/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
1Monoclonal AntibodiesIBA
04/2020
1Interleukin-2 (IL2)IBA
01/2020
1KPT-9274IBA
01/2020
1bempegaldesleukinIBA
01/2020
1p21-Activated KinasesIBA
01/2020
1Peptides (Polypeptides)IBA
01/2019
1EpitopesIBA
11/2018
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1Immunoglobulin G (IgG)IBA
09/2017
1Interferon gamma ReceptorIBA
01/2017
1CarcinogensIBA
10/2016
1Janus Kinase 1IBA
09/2016
1Interferon Receptors (Interferon Receptor)IBA
09/2016
1Janus Kinase 2IBA
09/2016
1Mitogen-Activated Protein KinasesIBA
03/2016
1Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA
05/2015
1VemurafenibIBA
05/2015
1pexidartinibIBA
05/2015
1Macrophage Colony-Stimulating FactorIBA
05/2015
1Cetuximab (Erbitux)FDA Link
08/2011
1ParaffinIBA
08/2011
1ErbB Receptors (EGF Receptor)IBA
08/2011
1Epidermal Growth Factor (EGF)IBA
08/2011
1Formaldehyde (Formol)FDA Link
08/2011
1Transferrin Receptors (Transferrin Receptor)IBA
10/2005
1Small Interfering RNA (siRNA)IBA
10/2005
1Transferrin (beta 2 Transferrin)IBA
10/2005
1CyclodextrinsIBA
10/2005
1Tetracycline (Achromycin)FDA LinkGeneric
06/2005

Therapy/Procedure

34Therapeutics
01/2024 - 10/2005
16Immunotherapy
06/2023 - 07/2014
2Neoadjuvant Therapy
03/2023 - 08/2011
1Aftercare (After-Treatment)
01/2024
1AT protocol
11/2021
1Intravenous Administration
07/2019
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2019
1Drug Therapy (Chemotherapy)
01/2018